[HTML][HTML] Antibiotics in the clinical pipeline as of December 2022
The need for new antibacterial drugs to treat the increasing global prevalence of drug-
resistant bacterial infections has clearly attracted global attention, with a range of existing …
resistant bacterial infections has clearly attracted global attention, with a range of existing …
ESKAPEing the labyrinth of antibacterial discovery
Antimicrobial drug resistance is a growing threat to global public health. Multidrug resistance
among the'ESKAPE'organisms—encompassing Enterococcus faecium, Staphylococcus …
among the'ESKAPE'organisms—encompassing Enterococcus faecium, Staphylococcus …
Antibiotic resistance—the need for global solutions
The causes of antibiotic resistance are complex and include human behaviour at many
levels of society; the consequences affect everybody in the world. Similarities with climate …
levels of society; the consequences affect everybody in the world. Similarities with climate …
[HTML][HTML] New agents for the treatment of drug-resistant Mycobacterium tuberculosis
DT Hoagland, J Liu, RB Lee, RE Lee - Advanced drug delivery reviews, 2016 - Elsevier
Inadequate dosing and incomplete treatment regimens, coupled with the ability of the
tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have …
tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have …
Aminoacyl-tRNA synthetases as therapeutic targets
Aminoacyl-tRNA synthetases (ARSs) are essential enzymes for protein synthesis with
evolutionarily conserved enzymatic mechanisms. Despite their similarity across organisms …
evolutionarily conserved enzymatic mechanisms. Despite their similarity across organisms …
The versatility of boron in biological target engagement
DB Diaz, AK Yudin - Nature Chemistry, 2017 - nature.com
Boron-containing molecules have been extensively used for the purposes of chemical
sensing, biological probe development and drug discovery. Due to boron's empty p orbital, it …
sensing, biological probe development and drug discovery. Due to boron's empty p orbital, it …
[HTML][HTML] Boron chemicals in drug discovery and development: Synthesis and medicinal perspective
BC Das, NK Nandwana, S Das, V Nandwana… - Molecules, 2022 - mdpi.com
A standard goal of medicinal chemists has been to discover efficient and potent drug
candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive …
candidates with specific enzyme-inhibitor abilities. In this regard, boron-based bioactive …
Challenges and opportunities for the application of boron clusters in drug design
ZJ Lesnikowski - Journal of medicinal chemistry, 2016 - ACS Publications
There are two branches in boron medicinal chemistry: the first focuses on single boron atom
compounds, and the second utilizes boron clusters. Boron clusters and their heteroatom …
compounds, and the second utilizes boron clusters. Boron clusters and their heteroatom …
Leaks in the pipeline: a failure analysis of gram-negative antibiotic development from 2010 to 2020
ABSTRACT The World Health Organization (WHO) has warned that our current arsenal of
antibiotics is not innovative enough to face impending infectious diseases, especially those …
antibiotics is not innovative enough to face impending infectious diseases, especially those …
The challenge of converting Gram‐positive‐only compounds into broad‐spectrum antibiotics
MF Richter, PJ Hergenrother - … of the New York Academy of …, 2019 - Wiley Online Library
Multidrug resistant Gram‐negative bacterial infections are on the rise, and there is a lack of
new classes of drugs to treat these pathogens. This drug shortage is largely due to the …
new classes of drugs to treat these pathogens. This drug shortage is largely due to the …